Comparative risk of gastrointestinal bleeding in patients with anticoagulants undergoing endoscopic treatment.

Comparative risk of gastrointestinal bleeding in patients with anticoagulants undergoing endoscopic treatment. - Comparative risk of gastrointestinal bleeding in patients with anticoagulants undergoing endoscopic treatment.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028764

Enrollment

100

Registered

2017-08-22

Start date

2017-08-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early esophageal cancer/early gastric cancer/early colon cancer/gastric adenoma/colon polyp

Interventions

The safety of anticoaglants

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who take anticoagulation.

Exclusion criteria

Exclusion criteria: Patients ineligible for this study. Patients administer treatment of hepalinization. Without the consent of the patients.

Design outcomes

Primary

Measure	Time frame
To evaluate the frequency of bleeding after treatment of endoscopy.	—

Secondary

Measure	Time frame
adverse event rate	—

Countries

Japan

Contacts

Public ContactYoshitaka Kitayama

Hyogo College of Medicine. Gastroenterology

yoshitaka591027@hyo-med.ac.jp0798-45-6662

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026